Результаты поиска

Managing treatment-related peripheral neuropathy in patients with multiple myeloma.

Peripheral neuropathy is one of the most important complications of multiple myeloma treatment. Neurological damage can be observed at the onset of the disease, due to the effect of monoclonal protein or radicular compression, but more often is treatment related. Vinca alkaloids in the past era, and more recently, thalidomide and bortezomib are mainly responsible. Degeneration of dorsal root ganglion is common, prevalently related to angiogenesis inhibition and cytokine modulation in the case of thalidomide and inhibition of the ubiquitin proteasome system in the case of bortezomib. Sensory ne

Инструменты скрининга для раннего выявления потребностей в паллиативном уходе у пациентов с повышенными хроническими условиями: обновленный систематический обзор.

Предыстория/задачи: Более раннее начало паллиативного ухода способствует улучшению клинических результатов, включая повышение эффективности мер по борьбе с симптомами, повышение качества жизни и сокращение использования ресурсов здравоохранения для лечения передовых заболеваний. Цель этого систематического обзора заключалась в выявлении и критической оценке существующих инструментов, разработанных как в обычном порядке, так и на основе искусственного интеллекта, предназначенных для выявления пациентов, имеющих право на раннее паллиативное лечение. Методы: Six Были изучены электронные базы данн

Совпадение в полном тексте источника
… Additionally, other conditions such as renal failure, chronic liver disease and neurodegenerative diseases like multiple sclerosis, Parkinson’s disease and dementia are increasingly recognized as requiring specialized PC services. …

Targeted therapy in the treatment of malignant gliomas.

Malignant gliomas are invasive tumors with the potential to progress through current available therapies. These tumors are characterized by a number of abnormalities in molecular signaling that play roles in tumorigenesis, spread, and survival. These pathways are being actively investigated in both the pre-clinical and clinical settings as potential targets in the treatment of malignant gliomas. We will review many of the therapies that target the cancer cell, including the epidermal growth factor receptor, mammalian target of rapamycin, histone deacetylase, and farnesyl transferase. In additi

Вирус Эпштейн-Барр BALF0/1 подрывает пути кавеолина и ERAD, чтобы охватить комплексы рецепторов клеток B для разложения.

Вирус Эпштейн-Барр (ЭБВ) устанавливает стойкую инфекцию, вызывает инфекционный мононуклеоз, является одним из основных пусковых факторов множественного склероза и способствует возникновению множественных раковых заболеваний. Тем не менее, знания о том, как вирус реконструирует клетки В для поддержки литического воспроизведения, остаются неполными. Ранее мы обнаружили, что EBV литическое воспроизведение приводит к избирательному истощению комплексов рецепторов клеток В (КРВ), состоящих из иммуноглобулина, а также цепочек сигнализации CD79A и CD79B. Здесь мы использовали протеомные и биохимическ

Совпадение в аннотации оригинала
Epstein-Barr virus (EBV) establishes persistent infection, causes infectious mononucleosis, is a major trigger for multiple sclerosis and contributes to multiple cancers. Yet, knowledge remains incomplete about how the virus remodels host B cells to support lytic replication. We previously identified that EBV lytic replication results in selective depletion …

Monoclonal Antibodies Approved for Cancer Therapy

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Совпадение в полном тексте источника
… Expressed on activated T and B lymphocytes o Withdrawn from the USA and Europe in 2012 to be relaunched for multiple sclerosis p CD52—present on the surface of mature lymphocytes and associated with some lymphomas q In particular Pneumocystis jirovecii , CMV, EBV, and herpesvirus r Not indicated for … Since 2012, alemtuzumab has been relaunched as Lemtrada ® for multiple sclerosis (see Chap. 10.1007/978-3-319-30472-4_2, Table 10.1007/978-3-319-30472-4_2#Tab1, and Chap. 10.1007/978-3-319-30472-4_4, section “Alemtuzumab”). …

Targeting Members of the Chemokine Family as a Novel Approach to Treating Neuropathic Pain.

Neuropathic pain is a debilitating condition that affects millions of people worldwide. Numerous studies indicate that this type of pain is a chronic condition with a complex mechanism that tends to worsen over time, leading to a significant deterioration in patients' quality of life and issues like depression, disability, and disturbed sleep. Presently used analgesics are not effective enough in neuropathy treatment and may cause many side effects due to the high doses needed. In recent years, many researchers have pointed to the important role of chemokines not only in the development and ma

Совпадение в полном тексте источника
… The available experimental studies indicate that CCR1 is involved in the pathogenesis of diseases with large neuroimmunological components, such as rheumatoid arthritis [ 208 , 210 , 229 ], disc inflammation [ 230 ], multiple sclerosis [ 231 , 232 ], and diabetes [ 19 ]. … Importantly, several CCR1 antagonists have entered clinical trials, including MLN3897 and CP-481,715 for rheumatoid arthritis, BX471 for multiple sclerosis, AZD-4818 for chronic obstructive pulmonary disease [ 233 ], and BAY86-5047 for endometriosis [ 234 ]. …

The Crosstalk Between B Cells and the Skeletal System During Development, Aging, and in Pathological Conditions.

Purpose of reviewIn this review, we describe the interaction between B cells and bone during development, aging, and disease. RECENT FINDINGS: There is an increased interest in identifying the mechanisms of interaction between immune cells and the skeletal system. This knowledge is critical for understanding the pathology of autoimmune diseases and developing therapeutic interventions. Humoral immunity depends on B cells and their secreted immunoglobulin (antibodies). Earlier studies described B cell influence on the skeletal system, with a major focus on the role of plasma cells and secreted

Совпадение в полном тексте источника
… Rituximab has been reported to have jaw and oral complications in patients treated for neurological autoimmune diseases such as multiple sclerosis [ 130 ]. …

Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28-29 2017, Doha, Qatar).

New technologies and therapies designed to facilitate development of personalized treatments are rapidly emerging in the field of biomedicine. Strikingly, the goal of personalized medicine refined the concept of therapy by developing cell-based therapies, the so-called "living drugs". Breakthrough advancements were achieved in this regard in the fields of gene therapy, cell therapy, tissue-engineered products and advanced therapeutic techniques. The Advanced Therapies in Healthcare symposium, organized by the Clinical Research Center Department of Sidra Medicine, in Doha, Qatar (October 2017),

Совпадение в полном тексте источника
… This is reflected by the increased numbers of published clinical trials—for example, in GvHD [ 57 ], Crohn’s disease (CD) [ 58 ] and multiple sclerosis [ 59 ]—and of ongoing clinical trials. … Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol. 2012;11:150–156. doi: 10.1016/S1474-4422(11)70305-2. 60. …

Перенос Митохондрии для ремонта миелина.

Обезвоживание является общей характеристикой нейро-воспалительных и дегенеративных заболеваний центральной нервной системы (КНС), таких, как множественный склероз (МС). Часто это связано с нарушениями межклеточной связи, биоэнергетики и метаболического баланса в сочетании с митохондриальной дисфункцией в таких клетках, как олигодендроциты, нейроны, астроциты и микроглиа. Несмотря на то, что нынешние методы лечения MS сосредоточены на иммуномодуляции, они не могут остановить или обратить вспять прогресс демиэлизации. Последние достижения подчеркивают межклеточный митохондриальный обмен в качест

Совпадение в аннотации оригинала
Demyelination is a common feature of neuroinflammatory and degenerative diseases of the central nervous system (CNS), such as multiple sclerosis (MS). It is often linked to disruptions in intercellular communication, bioenergetics and metabolic balance accompanied by mitochondrial dysfunction in cells such as oligodendrocytes, neurons, astrocytes, and microg…

Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results.

Chimeric antigen receptor (CAR) T-cell therapy that targets B-cell maturation antigen (BCMA) have great potentials in autoimmune diseases and could be novel therapeutics for relapsed/refractory neuromyelitis optica spectrum disorder (NMOSD). To evaluate the safety and efficacy of the CT103A, a self-developed BCMA-targeting CAR construct against BCMA, in patients with AQP4-IgG seropositive NMOSD, an ongoing, investigator-initiated, open-label, single-arm, phase 1 clinical trial is conducted at our center. In total, 12 patients were administered with a CAR-BCMA infusion. Ten of the 12 patients d

Совпадение в полном тексте источника
… Akaishi T Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica J. Neuroimmunol. 2015 283 70 73 10.1016/j.jneuroim.2015.05.007 26004160 23. …

Революционизация медицины сна: влияние машинного обучения на диагностику, лечение и индивидуальное лечение.

Преобразовательным инструментом в медицине сна стало обучение основам махинации (ML), предлагающее новаторские решения для диагностики, лечения и понимания расстройств сна. В настоящем обзоре рассматривается нынешнее состояние и будущий потенциал применения ML в этой области. Methods Мы провели всеобъемлющий обзор литературы с уделением особого внимания ключевым достижениям в области технологий ML, применяемых для лечения сна. Были изучены, в частности, такие конкретные области, как классификация стадий сна, оптимизация лечения апноэ и бессонницы сна, а также внедрение износостойкой технологии

Совпадение в полном тексте источника
… In patients with neurological disorders like multiple sclerosis and Parkinson's disease, ML models are being used to analyze sleep patterns, providing valuable insights into disease progression and its impact on sleep quality [ 37 , 40 ]. …

Воздействие совместных мероприятий на популяризацию пожилых людей: систематический обзор и метаанализ.

Справочная информация/задачи: Сочетание учений с когнитивной подготовкой (комбинированное вмешательство) является стратегией борьбы с обусловленным возрастом когнитивным упадком; однако по-прежнему не ясно, какой из наиболее оптимальных видов упражнений необходим для максимального повышения нейрозащитного воздействия комбинированного вмешательства. Таким образом, цель этого систематического обзора и метаанализа (СРПД) состояла в том, чтобы сопоставить воздействие комбинированных мероприятий (активизация плюс когнитивная подготовка) с воздействием только физических упражнений на когнитивную фун

Совпадение в полном тексте источника
… The exclusion criteria were studies with: (a) populations with dementia, major depression, Parkinson, multiple sclerosis, schizophrenia; (b) populations with metabolic diseases (e.g., obesity, diabetes); (c) populations with stroke; (d) that assessed supplement consumption effects; (e) with poor quality … Do baseline cognitive status, participant specific characteristics and EDSS impact changes of cognitive performance following aerobic exercise intervention in multiple sclerosis? Mult. Scler. Relat. Disord. 2021;51:102905. doi: 10.1016/j.msard.2021.102905. 105. …

Target inhibition of SPAK in choroid plexus attenuates T cell infiltration and demyelination in experimental autoimmune encephalomyelitis.

BACKGROUND: Disease-modifying therapies (DMTs) that prevent immune cell infiltration into the brain have demonstrated efficacy in multiple sclerosis (MS) treatment. However, their unpredictable adverse effects necessitate the development of safer therapeutic alternatives. The choroid plexus (ChP) functions as a crucial barrier against immune cell invasion, and previous studies have shown that preventing immune cell infiltration across the ChP reduces brain lesion in MS animal models. Understanding ChP barrier regulation is therefore essential for identifying novel therapeutic targets for MS. H…

Multiple-Drugs-Related Osteonecrosis of the Jaw in a Patient Affected by Multiple Myeloma: A Case Report.

A 60-year-old woman suffering from multiple myeloma (MM) was treated with zoledronic acid (bisphosphonate), dexamethasone (corticosteroid), bortezomib (a chemotherapeutic agent), and lenalidomide (thalidomide analog) for about a year and with lenalidomide alone as maintenance therapy for almost two years and developed stage three medication-related osteonecrosis of the jaws (MRONJ) in the upper left dental arch approximately two weeks after tooth extraction, which was treated with a medical nonoperative conservative approach until reversion to stage one. The present case report describing the

Усиление ремиэлизации в множестве склероза через M1 Muscarinic ацетилхолиновый рецептор.

Растет распространенность склероза (MS), однако по-прежнему требуется лечение, способное обратить вспять прогресс в развитии болезни. Одна из стратегий, которая продемонстрировала многообещающее изменение режима MS, заключается в воспрещении рецептора M1 — члена семейства мускаринических ацетилхолинов (mAChR). Считается, что антагонизм M1 mAChR является механизмом, с помощью которого Клемастин, развивающийся препарат, который был замечен в целях усиления миелинизации в исследованиях животных и клинических испытаниях этапа II, вызывает его эффект, стимулирующий миелинацию. Недавние исследования

Совпадение в аннотации оригинала
Multiple sclerosis (MS) is growing in prevalence; yet, treatments that can reverse the progression of the disease are still needed. One strategy that has shown promise for reversing MS is remyelination by inhibiting the M1 receptor, a member of the muscarinic acetylcholine receptor (mAChR) family. Antagonizing the M1 mAChR is believed to be the mechanism by …

PPARs in Irradiation-Induced Gastrointestinal Toxicity.

The use of radiation therapy to treat cancer inevitably involves exposure of normal tissues. Although the benefits of this treatment are well established, many patients experience distressing complications due to injury to normal tissue. These side effects are related to inflammatory processes, and they decrease therapeutic benefit by increasing the overall treatment time. Emerging evidence indicates that PPARs and their ligands are important in the modulation of immune and inflammatory reactions. This paper discusses the effects of abdominal irradiation on PPARs, their role and functions in i

Managing allorejection in off-the-shelf CAR-engineered cell therapies.

Chimeric antigen receptor (CAR)-engineered T (CAR-T) cell therapy has revolutionized the treatment of various diseases, including cancers and autoimmune disorders. However, all US Food and Drug Administration (FDA)-approved CAR-T cell therapies are autologous, and their widespread clinical application is limited by several challenges, such as complex individualized manufacturing, high costs, and the need for patient-specific selection. Allogeneic off-the-shelf CAR-engineered cell therapy offers promising potential due to its immediate availability, consistent quality, potency, and scalability

Therapeutic Modulation of Autophagy in Leukaemia and Lymphoma.

Haematopoiesis is a tightly orchestrated process where a pool of hematopoietic stem and progenitor cells (HSPCs) with high self-renewal potential can give rise to both lymphoid and myeloid lineages. The HSPCs pool is reduced with ageing resulting in few HSPC clones maintaining haematopoiesis thereby reducing blood cell diversity, a phenomenon called clonal haematopoiesis. Clonal expansion of HSPCs carrying specific genetic mutations leads to increased risk for haematological malignancies. Therefore, it comes as no surprise that hematopoietic tumours develop in higher frequency in elderly peopl

Narrative Review of Drug-Associated Nail Toxicities in Oncologic Patients.

IntroductionNail toxicity represents one of the most common cutaneous adverse effects of both classic chemotherapeutic agents and new oncologic drugs, including targeted treatments and immunotherapy.ObjectivesWe aimed to provide a comprehensive literature review of nail toxicities derived from conventional chemotherapeutic agents, targeted therapies (EGFR inhibitors, multikinase inhibitors, BRAF and MEK inhibitors) and immune checkpoint inhibitors (ICIs), including clinical presentation, implicated drugs and approaches for prevention and management.MethodsRetrieved literature from PubMed regis

Связанные с возрастом различия в структуре Choroid Plexus ассоциируются с изменениями в когниции.

Хороиды-плексус (CP) играют важнейшую роль в поддержании гомеостазиза центральной нервной системы (КНС), производстве цереброспинной жидкости и регулировании поступления конкретных веществ в ЦНС из крови. Дефункция ХП была связана с различными неврологическими и психическими расстройствами, включая болезнь Альцгеймера, болезнь Паркинсона и множественный склероз. В этом исследовании изучается взаимосвязь между структурной целостностью ХП и когнитивным снижением нормативных показателей старения с использованием структурных и передовых методов магнитного резонансного изображения, включая объем ХП

Совпадение в аннотации оригинала
The choroid plexus (CP) plays a critical role in maintaining central nervous system (CNS) homeostasis, producing cerebrospinal fluid, and re … ous neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. This study investigates the relationship between CP structural integrity and cognitive decline in normative aging, using structural and advanced magnetic resonance imaging techniques, including CP volume, diffusion tensor imaging indices (mean diff …